NZD 0.03
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2024 | -0.09 NZD | -123.45% |
2023 | -0.04 NZD | 32.64% |
2022 | -0.06 NZD | -70.41% |
2021 | -0.03 NZD | -68.16% |
2020 | -0.02 NZD | -42.55% |
2019 | -0.01 NZD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 FY | - NZD | -123.45% |
2024 Q2 | -0.07 NZD | -98.84% |
2024 Q4 | -0.02 NZD | 0.0% |
2024 Q1 | -0.03 NZD | 18.25% |
2023 FY | - NZD | 32.64% |
2023 Q2 | 0.00 NZD | 130.0% |
2023 Q4 | -0.04 NZD | -100.95% |
2023 Q1 | 0.00 NZD | 104.85% |
2023 Q3 | -0.02 NZD | -556.52% |
2022 Q1 | -0.01 NZD | 32.89% |
2022 FY | - NZD | -70.41% |
2022 Q4 | -0.04 NZD | -120.32% |
2022 Q3 | -0.02 NZD | -7.47% |
2022 Q2 | -0.02 NZD | -74.0% |
2021 FY | - NZD | -68.16% |
2021 Q4 | -0.01 NZD | -98.67% |
2021 Q3 | -0.01 NZD | 54.82% |
2021 Q2 | -0.02 NZD | -66.0% |
2021 Q1 | -0.01 NZD | 9.09% |
2020 FY | - NZD | -42.55% |
2020 Q2 | -0.01 NZD | -94.0% |
2020 Q4 | -0.01 NZD | 17.29% |
2020 Q1 | -0.01 NZD | 0.0% |
2020 Q3 | -0.01 NZD | -37.11% |
2019 FY | - NZD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
AFT Pharmaceuticals Limited | 0.15 NZD | 157.8% |
Greenfern Industries Limited | -0.03 NZD | -195.904% |